查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1841943

美国人工角膜植入市场：市场规模、份额、趋势分析（按移植类型、适应症、植入类型、最终用途）、细分市场预测（2025-2033）

U.S. Artificial Corneal Implants Market Size, Share & Trends Analysis Report By Transplant Type, By Indication, By Implant Type, By End-use, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国人工角膜植入市场摘要

预计 2024 年美国人工角膜植入市场价值为 3,910 万美元，到 2033 年将达到 6,980 万美元，2025 年至 2033 年的复合年增长率为 6.7%。

市场的发展受到角膜疾病（如角膜失明）盛行率的不断上升以及角膜捐赠者的短缺的推动，导致患者和外科医生寻求人工替代方案。

圆锥角膜、史蒂文斯-约翰逊症候群和角膜瘢痕等视力障碍主要病因的增多，推动了市场的发展。随着美国人口老化，这些疾病的发生率不断上升，进一步推动了对有效治疗方法的需求。根据美国国家老龄委员会的数据，到2022年，美国65岁及以上成年人口将达到5,780万，其中包括3,190万名女性和2,590万男性。

为了满足这项需求，主要市场参与企业正在大力投资研发、获得监管部门的核准，并与临床和学术机构合作推出创新的植入解决方案。伙伴关係、地理扩张和先进生医材料的整合等策略性倡议将加强竞争地位并扩大市场范围。 2025 年 1 月，Pantheon Vision 与 Ideal Medical 合作，推进生物工程植入的生产和商业化。 Pantheon 已完成三次 FDA 上市前核准(PMA) 指南审查会议。此次合作旨在透过提供生物工程角膜植入来解决捐赠角膜的局限性，从而为角膜失明患者恢復视力。

目录

第一章 分析方法与范围

第二章执行摘要

第三章人工角膜植入市场：因素、趋势与范围

  • 市场概况/相关展望
  • 市场规模和成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 美国人工角膜植入市场：分析工具
    • 波特五力分析
    • PESTEL分析

第四章美国人工角膜植入市场：按植入物类型进行的估计和趋势分析

  • 细分仪表板
  • 美国人工角膜植入市场分析（按植入物类型）（2024 年和 2033 年）
  • 硬性人工替代物
    • 硬性人工替代物：收益估计值与预测（2021-2033）
    • 波士顿 K 职业队
    • 根角人工替代物
  • 软性人工替代物
    • 软性人工替代物：收益估计值与预测（2021-2033）

第五章美国人工角膜植入市场：依适应症的估计与趋势分析

  • 细分仪表板
  • 美国人工角膜植入市场分析（依适应症划分）（2024 年和 2033 年）
  • 史蒂文斯-约翰逊症候群（SJS）
    • 史蒂文斯-约翰逊症候群 (SJS)：收益估计值和预测（2021-2033）
  • 眼部瘢痕性类天疱疮（OCP）
    • 眼部瘢痕性类天疱疮 (OCP)：收益估计值与预测（2021-2033）
  • 眼部烧烫伤
    • 眼烧伤：收益估计值与预测（2021-2033）
  • 圆锥角膜
    • 圆锥角膜：收益估计值与预测（2021-2033）
  • 角膜基质营养不良
    • 角膜基质营养不良：收益估计值和预测（2021-2033）
  • 其他的
    • 2021-2033年其他收益估算与预测

第六章美国人工角膜植入市场：按植入类型进行的估计和趋势分析

  • 细分仪表板
  • 美国人工角膜植入市场分析（按植入类型）（2024 年和 2033 年）
  • 合成
    • 综合：收益估计值与预测（2021-2033）
  • 生物合成
    • 生物合成：收益估计值与预测（2021-2033）

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 公司热图分析
  • 公司简介
    • CorneaGen
    • AJL Ophthalmic SA
    • Alcon inc.
    • KeraMed, Inc.
    • FCI
Product Code: GVR-4-68040-757-7

U.S. Artificial Corneal Implants Market Summary

The U.S. artificial corneal implants market size was estimated at USD 39.1 million in 2024 and is projected to reach USD 69.8 million by 2033, growing at a CAGR of 6.7% from 2025 to 2033. The market is driven by an increasing prevalence of corneal disorders such as corneal blindness and a shortage of cornea donors, which is leading patients and surgeons to seek synthetic alternatives.

The market is driven by increasing incidences of Keratoconus, Stevens-Johnson syndrome, and corneal scarring, which remain leading causes of vision impairment. The increasing prevalence of these disorders among the aging U.S. population has further increased the need for effective treatment solutions. According to the National Council on Aging, in 2022, the U.S. had 57.8 million adults aged 65 and older, comprising 31.9 million women and 25.9 million men.

To address this demand, key market participants invest heavily in R&D, securing regulatory approvals, and collaborating with clinical and academic institutions to introduce innovative implant solutions. Strategic initiatives, including partnerships, geographic expansion, and integration of advanced biomaterials, enhance their competitive positioning and expand market reach. In January 2025, Pantheon Vision collaborated with Eyedeal Medical to advance production and commercialization of its bioengineered corneal implant. Pantheon completed three FDA review meetings for Premarket approval (PMA) guidance. The partnership aimed to address limitations of donor corneas by offering bioengineered corneal implants and restoring vision in patients with corneal blindness.

U.S. Artificial Corneal Implants Market Report Segmentation

This report forecasts revenue growth at country level as well as provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artificial corneal implants market report on the basis of transplant type, indication, implant type, and end-use:

  • Transplant Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Hard Keratprosthesis
    • Boston Kpro
    • Osteo-Odonto-Keratoprosthesis
  • Soft Keratoprosthesis
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Stevens-Johnson Syndrome (SJS)
  • Ocular Cicatricial Pemphigoid (OCP)
  • Ocular burns
  • Keratoconus
  • Corneal Stromal Dystrophies
  • Others
  • Implant Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Synthetic
  • Biosynthetic
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ophthalmic Centers
  • Ambulatory Surgical Centers

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
  • 1.4. Information Procurement
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Artificial Corneal Implants Market Variables, Trends & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. U.S. Artificial Corneal Implants Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Political landscape
      • 3.4.1.2. Economic and Social landscape
      • 3.4.1.3. Technological landscape
      • 3.4.1.4. Environmental landscape
      • 3.4.1.5. Legal landscape
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Bargaining power of the suppliers
      • 3.4.2.2. Bargaining power of the buyers
      • 3.4.2.3. Threats of substitution
      • 3.4.2.4. Threats from new entrants
      • 3.4.2.5. Competitive rivalry

Chapter 4. U.S. Artificial Corneal Implants Market: Transplant Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Artificial Corneal Implants Market: Transplant Type Analysis, 2024 & 2033 (USD Million)
  • 4.3. Hard Keratoprosthesis
    • 4.3.1. Hard Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Boston Kpro
      • 4.3.2.1. Boston Kpro Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Osteo-Odonto-Keratoprosthesis
      • 4.3.3.1. Osteo-Odonto-Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Soft Keratoprosthesis
    • 4.4.1. Soft Keratoprosthesis Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Artificial Corneal Implants Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Artificial Corneal Implants Market: Indication Analysis, 2024 & 2033 (USD Million)
  • 5.3. Stevens-Johnson syndrome (SJS)
    • 5.3.1. Stevens-Johnson syndrome (SJS) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Ocular Cicatricial Pemphigoid (OCP)
    • 5.4.1. Ocular Cicatricial Pemphigoid (OCP) Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ocular Burns
    • 5.5.1. Ocular Burns Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Keratoconus
    • 5.6.1. Keratoconus Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Corneal Stromal Dystrophies
    • 5.7.1. Corneal Stromal Dystrophies Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Artificial Corneal Implants Market: Implant Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Artificial Corneal Implants Market: Implant Type Analysis, 2024 & 2033 (USD Million)
  • 6.3. Synthetic
    • 6.3.1. Synthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Biosynthetic
    • 6.4.1. Biosynthetic Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. CorneaGen
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. AJL Ophthalmic S.A.
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Alcon inc.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. KeraMed, Inc.
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. FCI
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. artificial corneal implants market 2021 - 2033 (USD Million)
  • Table 3 U.S. artificial corneal implants market: key market driver analysis
  • Table 4 U.S. artificial corneal implants market: key market restraint analysis
  • Table 5 U.S. artificial corneal implants market estimates and forecast, by transplant type (USD Million)
  • Table 6 U.S. artificial corneal implants market estimates and forecast, by indication (USD Million)
  • Table 7 U.S artificial corneal implants market estimates and forecast, by implant type (USD Million)
  • Table 8 U.S artificial corneal implants market estimates and forecast, by end use (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. artificial corneal implants: market outlook
  • Fig. 10 U.S. artificial corneal implants competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. artificial corneal implants driver impact
  • Fig. 16 U.S. artificial corneal implants restraint impact
  • Fig. 17 U.S. artificial corneal implants strategic initiatives analysis
  • Fig. 18 U.S. artificial corneal implants: Transplant type movement analysis
  • Fig. 19 U.S. artificial corneal implants: Transplant type outlook and key takeaways
  • Fig. 20 Hard keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 21 Boston Kpro estimates and forecast, 2021 - 2033
  • Fig. 22 Osteo-odonto-keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 23 Soft keratoprosthesis estimates and forecast, 2021 - 2033
  • Fig. 24 U.S. artificial corneal implants: Indication movement analysis
  • Fig. 25 U.S. artificial corneal implants: Indication outlook and key takeaways
  • Fig. 26 Stevens-Johnson syndrome (SJS) estimates and forecasts, 2021 - 2033
  • Fig. 27 Ocular cicatricial pemphigoid (OCP) estimates and forecasts, 2021 - 2033
  • Fig. 28 Ocular burn estimates and forecasts, 2021 - 2033
  • Fig. 29 Keratoconus estimates and forecasts, 2021 - 2033
  • Fig. 30 Corneal stromal dystrophies estimate and forecasts, 2021 - 2033
  • Fig. 31 OtherOthers estimates and forecasts, 2021 - 2033
  • Fig. 32 U.S. artificial corneal implants: Implant type movement analysis
  • Fig. 33 U.S. artificial corneal implants: Implant type outlook and key takeaways
  • Fig. 34 Synthetic estimates and forecasts, 2021 - 2033
  • Fig. 35 Biosynthetic estimates and forecasts, 2021 - 2033
  • Fig. 36 U.S. artificial corneal implants: End use movement analysis
  • Fig. 37 U.S. artificial corneal implants: End use outlook and key takeaways
  • Fig. 38 Hospitals estimates and forecasts, 2021 - 2033
  • Fig. 39 Ophthalmic center estimates and forecasts, 2021 - 2033
  • Fig. 40 Ambulatory surgical center estimates and forecasts, 2021 - 2033